These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26428870)

  • 1. Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents.
    Magri A; Reilly R; Scalacci N; Radi M; Hunter M; Ripoll M; Patel AH; Castagnolo D
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5372-6. PubMed ID: 26428870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV).
    Magri A; Mokrane O; Lauder K; Patel AH; Castagnolo D
    Bioorg Med Chem Lett; 2019 Mar; 29(5):724-728. PubMed ID: 30661824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of bimorpholine and its carbanucleoside.
    Ausmees K; Selyutina A; Kütt K; Lippur K; Pehk T; Lopp M; Zusinaite E; Merits A; Kanger T
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):897-907. PubMed ID: 22060554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
    Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV.
    Makino T; Yoshimura S; Neya M; Yamanaka T; Sawada M; Tsujii E; Barrett D
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127308. PubMed ID: 32631528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole Derivatives.
    Lillsunde KE; Tomašič T; Schult P; Lohmann V; Kikelj D; Tammela P
    ChemMedChem; 2019 Feb; 14(3):334-342. PubMed ID: 30548820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity.
    Yu W; Coburn CA; Yang DY; Meinke PT; Wong M; Rosenblum SB; Chen KX; Njoroge GF; Chen L; Dwyer MP; Jiang Y; Nair AG; Selyutin O; Tong L; Zeng Q; Zhong B; Ji T; Hu B; Agrawal S; Xia E; Zhai Y; Liu R; Kong R; Ingravallo P; Asante-Appiah E; Nomeir A; Fells J; Kozlowski JA
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3158-3162. PubMed ID: 27180013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potent macrocyclic HCV NS5A inhibitors.
    Yu W; Vibulbhan B; Rosenblum SB; Martin GS; Vellekoop AS; Holst CL; Coburn CA; Wong M; Selyutin O; Ji T; Zhong B; Hu B; Chen L; Dwyer MP; Jiang Y; Nair AG; Tong L; Zeng Q; Agrawal S; Carr D; Rokosz L; Liu R; Curry S; McMonagle P; Ingravallo P; Lahser F; Asante-Appiah E; Fells J; Kozlowski JA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3793-9. PubMed ID: 27282743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
    Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
    ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
    Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
    Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
    He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
    ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation.
    Zhang H; Zheng X; Li J; Liu Q; Huang XX; Ding H; Suzuki R; Muramatsu M; Song SJ
    Eur J Med Chem; 2021 Jun; 218():113395. PubMed ID: 33838584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold.
    Andreev IA; Manvar D; Barreca ML; Belov DS; Basu A; Sweeney NL; Ratmanova NK; Lukyanenko ER; Manfroni G; Cecchetti V; Frick DN; Altieri A; Kaushik-Basu N; Kurkin AV
    Eur J Med Chem; 2015; 96():250-8. PubMed ID: 25890075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly.
    Rolt A; Talley DC; Park SB; Hu Z; Dulcey A; Ma C; Irvin P; Leek M; Wang AQ; Stachulski AV; Xu X; Southall N; Ferrer M; Liang TJ; Marugan JJ
    J Med Chem; 2021 Jul; 64(13):9431-9443. PubMed ID: 34184537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in HCV therapy: entry inhibitors.
    Donia M; Cacopardo B; Libra M; Scalia G; McCubrey JA; Nicoletti F
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):181-94. PubMed ID: 20497122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication.
    Kusano-Kitazume A; Sakamoto N; Okuno Y; Sekine-Osajima Y; Nakagawa M; Kakinuma S; Kiyohashi K; Nitta S; Murakawa M; Azuma S; Nishimura-Sakurai Y; Hagiwara M; Watanabe M
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1315-23. PubMed ID: 22203602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
    J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis C virus infection by polyoxometalates.
    Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
    Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.